{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:37:00Z","timestamp":1790627820593,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.oret.2020.01.024","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T02:38:50Z","timestamp":1581561530000},"page":"461-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Topical Nonsteroidal Anti-inflammatory Drugs for Pain Resulting from Intravitreal Injections: A Meta-Analysis"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-5968","authenticated-orcid":false,"given":"Marko M.","family":"Popovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-1345","authenticated-orcid":false,"given":"Prem","family":"Nichani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2020.01.024_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.3.5.7","article-title":"Novel approaches for retinal drug and gene delivery","volume":"3","author":"Kim","year":"2014","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.oret.2020.01.024_bib2","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ophtha.2010.02.032","article-title":"A\u00a0treat and extend regimen using ranibizumab for neovascular age-related macular degeneration: clinical and economic impact","volume":"117","author":"Gupta","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.024_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ophtha.2019.01.013","article-title":"Canadian treat-and-extend analysis trial with ranibizumab in patients with neovascular age-related macular disease: one-year results of the randomized Canadian Treat-and-Extend Analysis Trial with Ranibizumab study","volume":"126","author":"Kertes","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.01.024_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2010.08.039","article-title":"Survey of intravitreal injection techniques among retinal specialists in the United States","volume":"151","author":"Green-Simms","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.024_bib5","series-title":"Intravitreal injections","year":"2015"},{"key":"10.1016\/j.oret.2020.01.024_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/23258160-20140306-08","article-title":"Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"45","author":"Fileta","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2020.01.024_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1755-3768.2010.02064.x","article-title":"Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections","volume":"89","author":"Meyer","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.024_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.5301\/ejo.5000147","article-title":"Shortening ocular pain duration following intravitreal injections","volume":"22","author":"Rifkin","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.024_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/03009749609097226","article-title":"Mechanism of action of anti-inflammatory drugs","volume":"25","author":"Vane","year":"1996","journal-title":"Scand J Rheum"},{"key":"10.1016\/j.oret.2020.01.024_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.oret.2020.01.024_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"10.1016\/j.oret.2020.01.024_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill pain questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.oret.2020.01.024_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/emj.18.3.205","article-title":"The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain","volume":"18","author":"Kelly","year":"2001","journal-title":"Emerg Med J"},{"key":"10.1016\/j.oret.2020.01.024_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.oret.2019.04.022","article-title":"Pain control after intravitreal injection using topical nepafenac 0.3% or pressure patching: a randomized, placebo-controlled trial","volume":"3","author":"Kaplan","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2020.01.024_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/02713683.2012.758290","article-title":"Ocular pain after intravitreal injection","volume":"38","author":"Sanabria","year":"2013","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2020.01.024_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ceo.12988","article-title":"Diclofenac for pain associated with intravitreal injections: a prospective, randomized, placebo-controlled study","volume":"45","author":"Makri","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.01.024_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/02713683.2018.1461908","article-title":"Analgesic effect of topical nepafenac 0.1% on pain related to intravitreal injections: a randomized crossover study","volume":"43","author":"Makri","year":"2018","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.oret.2020.01.024_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/IAE.0000000000001137","article-title":"Effect of bromfenac on pain related to intravitreal injections: a randomized crossover study","volume":"37","author":"Georgakopoulos","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.oret.2020.01.024_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/jop.2012.0023","article-title":"Effect of ketorolac 0.5% drops on patients\u2019 pain perception during intravitreal injection procedure","volume":"28","author":"Georgakopoulos","year":"2012","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2020.01.024_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/IAE.0b013e3182a0e611","article-title":"Topical nepafenac after intravitreal injection: a prospective double-masked randomized controlled trial","volume":"34","author":"Ulrich","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2020.01.024_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/jop.2018.0113","article-title":"Analgesic effect of a single drop of nepafenac 0.3% on pain associated with intravitreal injections: a randomized clinical trial","volume":"35","author":"Georgakopoulos","year":"2019","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.oret.2020.01.024_bib23","series-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0","year":"2011"},{"key":"10.1016\/j.oret.2020.01.024_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2020.01.024_bib25","first-page":"1594","article-title":"Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment","volume":"344","author":"Hrobjartsson","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2020.01.024_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2296-5-10","article-title":"Topical NSAIDs for acute pain: a meta-analysis","volume":"5","author":"Mason","year":"2004","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.oret.2020.01.024_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004397-200201000-00003","article-title":"Topical nonsteroidal anti-inflammatory drugs in ophthalmology","volume":"42","author":"Flach","year":"2002","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.oret.2020.01.024_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcjo.2017.08.003","article-title":"Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario","volume":"53","author":"Popovic","year":"2018","journal-title":"Can J Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020300555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020300555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:15Z","timestamp":1762853235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653020300555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2468653020300555"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2020.01.024","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Nonsteroidal Anti-inflammatory Drugs for Pain Resulting from Intravitreal Injections: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2020.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}